133 related articles for article (PubMed ID: 36320043)
21. A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.
Li X; Xu W; Xiong S
Clin Vaccine Immunol; 2012 May; 19(5):723-30. PubMed ID: 22461526
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.
Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM
Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443
[TBL] [Abstract][Full Text] [Related]
23. DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.
Chikhlikar P; Barros de Arruda L; Maciel M; Silvera P; Lewis MG; August JT; Marques ET
PLoS One; 2006 Dec; 1(1):e135. PubMed ID: 17205139
[TBL] [Abstract][Full Text] [Related]
24. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
[TBL] [Abstract][Full Text] [Related]
26. Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
Chen SMY; Wong YC; Yim LY; Zhang H; Wang H; Lui GCY; Li X; Tang X; Cheng L; Du Y; Peng Q; Wang J; Kwok HY; Huang H; Lau TT; Chan DPC; Wong BCK; Liu L; Chakrabarti LA; Lee SS; Chen Z
J Virol; 2022 Apr; 96(7):e0216121. PubMed ID: 35297660
[TBL] [Abstract][Full Text] [Related]
27. Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
Korsholm KS; Karlsson I; Tang ST; Brandt L; Agger EM; Aagaard C; Andersen P; Fomsgaard A
PLoS One; 2013; 8(5):e63575. PubMed ID: 23691069
[TBL] [Abstract][Full Text] [Related]
28. DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
Liu W; Wong YC; Chen SMY; Tang J; Wang H; Cheung AKL; Chen Z
Vaccine; 2018 Jul; 36(31):4621-4632. PubMed ID: 29961605
[TBL] [Abstract][Full Text] [Related]
29. Construction and immunogenicity of Salmonella vaccine vector expressing HIV-1 antigen and MCP3.
Bachtiar EW; Coloe PJ; Smooker PM
Acta Microbiol Immunol Hung; 2009 Dec; 56(4):403-15. PubMed ID: 20038492
[TBL] [Abstract][Full Text] [Related]
30. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
[TBL] [Abstract][Full Text] [Related]
32. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.
Kulkarni V; Valentin A; Rosati M; Rolland M; Mullins JI; Pavlakis GN; Felber BK
PLoS One; 2014; 9(10):e111085. PubMed ID: 25338098
[TBL] [Abstract][Full Text] [Related]
34. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV
Valentin A; Bergamaschi C; Rosati M; Angel M; Burns R; Agarwal M; Gergen J; Petsch B; Oostvogels L; Loeliger E; Chew KW; Deeks SG; Mullins JI; Pavlakis GN; Felber BK
Front Immunol; 2022; 13():945706. PubMed ID: 35935984
[TBL] [Abstract][Full Text] [Related]
35. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
[TBL] [Abstract][Full Text] [Related]
36. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN
Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.
Aline F; Brand D; Pierre J; Roingeard P; Séverine M; Verrier B; Dimier-Poisson I
Vaccine; 2009 Aug; 27(38):5284-91. PubMed ID: 19450633
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c.
Larijani MS; Sadat SM; Bolhassani A; Khodaie A; Pouriayevali MH; Ramezani A
Curr Drug Deliv; 2021; 18(7):1014-1021. PubMed ID: 33388019
[TBL] [Abstract][Full Text] [Related]
39. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
[TBL] [Abstract][Full Text] [Related]
40. Development of a DNA-MVA/HIVA vaccine for Kenya.
Hanke T; McMichael AJ; Mwau M; Wee EG; Ceberej I; Patel S; Sutton J; Tomlinson M; Samuel RV
Vaccine; 2002 May; 20(15):1995-8. PubMed ID: 11983261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]